Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

NCT02807779 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02807779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02807779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
February 10, 2016
Completion date
October 31, 2022
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral artery disease, vascular disease